← Dashboard
Aug 14, 2026 04:21 AM ET
Signal
FDA/Bio
Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance
PDUFA date set for Tinlarebant after FDA priority review acceptance.
What changed
PDUFA date set for Tinlarebant after FDA priority review acceptance.
Why it matters
PDUFA date set for Tinlarebant after FDA priority review acceptance. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →